ArticlePDF Available

Abstract

The world has been suffering from COVID-19 since 2019. It is thought that there is a high risk of dysphagia in patients with COVID-19. Therefore, the purpose of this study was to estimate the prevalence of dysphagia in patients affected by COVID-19 in admission (day 0), discharge, and 3-6 months post-discharge. Only English papers reporting dysphagia in COVID19 patients were included. Case reports and review studies were excluded. The authors searched Web of Science, Google Scholar, Scopus, and PubMed from January 1, 2020, until July 1, 2022. In this study, the effect sizes and standard errors were used to estimate the amount of dysphagia in these patients. Random effects were used for statistical analysis. Of the 2736 identified studies, 19 articles (n = 5334 patients) were included in the meta-analysis. The pooled prevalence of dysphagia in COVID-19 patients at admission (n=643 patients), discharge (n=2286 patients), long-term (n=2405 patients), and the total was 32% (SE=0.13), 29% (SE=0.04), 14% (SE=0.03), and 24% (SE=0.03), respectively. About a quarter of COVID-19 patients may have dysphagia during the acute phase and/or also in the post-acute phase of the disease. Therefore, one should be aware of the symptoms of dysphagia and treat it in time.
INTERNATIONAL JOURNAL OF HEALTH & MEDICAL RESEARCH
ISSN(print): 2833-213X, ISSN(online): 2833-2148
Volume 02 Issue 07 July 2023
10.58806/ijhmr.2023.v2i7n03DOI :
Page No.-172-181
IJHMR, Volume 2 Issue 7 July 2023 www.ijhmr.com Page 172
The Prevalence of Dysphagia in Patients with Covid-19: A Systematic Review
and Meta-Analysis
Akbar Banari1, Alireza Aghaz2, Arash Shahriyari3, Fatemeh Fakhimi4, Mohadeseh Khoshgoftar5
1Department of Speech Therapy, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
ORCID: 0000-0001-8432-6435
2 Department of Speech Therapy, School of Rehabilitation Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
ORCID: 0000-0002-6183-0214
3Department of Speech Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.
ORCID: 0000-0003-1989-2101
4Department of Speech Therapy, School of Rehabilitation Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
ORCID: 0000-0003-0260-7458
5PhD Student in Health Education and Health promotion, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.
ORCID: 0000-0002-6870-3920
ABSTRACT: The world has been suffering from COVID-19 since 2019. It is thought that there’s a high risk of dysphagia in
patients with COVID-19. Therefore, the purpose of this study was to estimate the prevalence of dysphagia in patients affected by
COVID-19 in admission (day 0), discharge, and 3-6 months post-discharge. Only English papers reporting dysphagia in COVID-
19 patients were included. Case reports and review studies were excluded. The authors searched Web of Science, Google Scholar,
Scopus, and PubMed from January 1, 2020, until July 1, 2022. In this study, the effect sizes and standard errors were used to estimate
the amount of dysphagia in these patients. Random effects were used for statistical analysis. Of the 2736 identified studies, 19
articles (n = 5334 patients) were included in the meta-analysis. The pooled prevalence of dysphagia in COVID-19 patients at
admission (n=643 patients), discharge (n=2286 patients), long-term (n=2405 patients), and the total was 32% (SE=0.13), 29%
(SE=0.04), 14% (SE=0.03), and 24% (SE=0.03), respectively. About a quarter of COVID-19 patients may have dysphagia during
the acute phase and/or also in the post-acute phase of the disease. Therefore, one should be aware of the symptoms of dysphagia
and treat it in time.
KEYWORDS: Prevalence; Dysphagia; Swallowing; COVID-19; Meta-analysis; Review
INTRODUCTION
The Coronavirus disease-2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has
resulted in a worldwide catastrophic healthcare issue, with serious social, economic, and health problems [1]. The high number of
COVID-19 patients has caused a great number of hospital and intensive care unit (ICU) admissions [2]. The SARS-CoV-2 virus
causes damage to the heart, digestive system, lungs, peripheral and central nervous system, and other tissues in some diseased people
[3, 4]. Its transmission through contact, fomites, respiratory droplets, and aerosols has facilitated the quick spread worldwide [1].
The most common manifestations appear to be sore throat, fever, cough, fatigue, and breathing difficulties [5-7]. COVID-19 can
cause life-threatening conditions in older patients or those with respiratory or cardiac diseases, which can result in the development
of Acute Respiratory Distress Syndrome (ARDS) [1, 6]. Besides these common manifestations of COVID-19, a few studies on
clinical features of these patients have reported a number of symptoms and disorders related to speech and swallowing, such as
dysphagia and dysphonia [3, 4, 6, 8-10].
Dysphagia in patients affected by COVID-19 seems to result from breathing-swallowing incoordination [11]. A study examined the
relationship between COVID-19 and dysphagia exhibited that the manifestations of COVID-19, like ARDS, neurological
manifestations, loss of taste, dyspnea, and tachypnea, as well as treatment actions for this disease, including oxygen therapy, non-
invasive mechanical ventilation, intubation, tracheostomy, and drugs used in the ICUs setting, affect swallowing efficiency
Negatively [12]. However, there is still much unknown about the underlying processes of COVID-19-related swallowing disorders,
and further research is needed [13, 14].
The Prevalence of Dysphagia in Patients with Covid-19: A Systematic Review and Meta-Analysis
173Page com.ijhmrwww. 3 220 7 July Issue 2IJHMR, Volume
Dysphagia prevalence in patients diagnosed with COVID-19 ranges from 7% [7] to 90% in different studies [8]. Martin-Martinez
et al. [15] in 2021, investigated the prevalence of dysphagia in 205 patients affected by COVID-19 admitted to the ward of a hospital
placed in Spain. The study reported that the prevalence of dysphagia at admission was 51.7% according to Volume-Viscosity
Swallowing Test (V-VST) and Eating Assessment Tool-10 (EAT-10). Mallart et al. [9] in France, conducted a cohort study of
patients with COVID-19 admitted to the ICU to explore the prevalence of dysphagia. The study found 22% of the patients had
dysphagia on discharge. Other researchers discovered a different dysphagia prevalence due to COVID-19, with Regan et al.
reporting a prevalence of 84% and Cerutia et al. reporting 54.8% [4, 16].
In some cities, sometimes because of the lack of diagnostic kits, COVID-19 diagnosis relies on evaluating the main clinical
symptoms [17]. Although some COVID-19 patients might not visit a physician, so Speech and Language Pathologists (SLPs) should
be completely aware of these symptoms in order to be capable of taking the necessary actions. As the number of COVID-19 patients
increases around the world [3], it is necessary for all clinicians, including SLPs, to be informed about the leading clinical
manifestations of COVID-19 patients. Based on the previous data, some researchers have reported dysphagia along with other
common symptoms of this disease, but these studies’ results are contradictory. On the other hand, dysphagia may lead to
complications such as pneumonia, malnutrition, dehydration, increased length of hospitalization, and mortality and a negative
impact on quality of life [13, 18]. So, it is needed that the impact of COVID-19 on this function be studied so early identification
and management can be provided. The available studies have investigated different strains of COVID-19 and different strains have
different effects on organs such as the brain and human functions. However, these studies were carried out at different time points
after the infection of these patients. These are reasons for the difference in reported dysphagia rates. To the best of the author's
knowledge, no meta-analysis study reported the presence of dysphagia in COVID-19 patients admitted to hospitals and during the
follow-up time. This may give us a view of the period of time (admission to hospital, discharge, or long-term) in which the
prevalence of dysphagia is higher in these patients. Therefore, the present study was designed to estimate the prevalence of dysphagia
in COVID-19 patients at three different time points: at admission, at discharge, and 3-6 months post-discharge or after their positive
SARS-CoV-2 test result.
MATERIALS AND METHODS
Search strategy
The authors reported this research based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
statement and with PROSPERO registration number: CRD42023405377 [19]. For finding relevant studies, four famous medical
databases, including PubMed, Web of Science, Scopus, and Google Scholar were searched from January 1, 2020, until July 1, 2022.
The search terms were applied according to English MeSH keywords: [COVID-19 AND dysphagia] OR [COVID-19 AND
Deglutition] OR [SARS-CoV-2 AND Swallowing disorder] OR [Coronavirus AND Prevalence] OR [Coronavirus AND Incidence]
OR [Wuhan Coronavirus AND Characteristics] OR [new coronavirus AND characteristics]. Furthermore, the Centers for Disease
Control and Prevention (CDC) and the World Health Organization (WHO) portals were appraised as national public health
organizations.
Inclusion and exclusion criteria
Any related paper that reported dysphagia in patients affected by COVID-19 at the time of admission, at the time of hospital
discharge, or 3-6 months post-discharge or after their positive SARS-CoV-2 test result, was entered into this analysis. All article
designs (cross-sectional studies, case-control studies, non-randomized controlled trials, and randomized controlled trials) were
entered. Only articles in English were entered and reviewed. Review studies were excluded from this study. Since the sample
numbers are important in meta-analysis research, case report articles were excluded too. Only the characteristics of adult patients
were included.
Data extraction and paper quality evaluation
The first and second authors separately extracted and evaluated the data. Two researchers separately extracted the country of
implementation, year of publication, sample size, average age, gender, dysphagia assessment method, and the number of patients
who had dysphagia from the articles that met the inclusion criteria and entered them into a table. After the completion of data
extraction, the two researchers shared their final tables and any disagreement between the judgments of the two was resolved by
consulting and discussing with the third author. The Newcastle-Ottawa scale (NOS) was used to evaluate all the included articles
[20], and the results were listed in Tables 1 & 2 & 3.
The Prevalence of Dysphagia in Patients with Covid-19: A Systematic Review and Meta-Analysis
174Page com.ijhmrwww. 3 220 7 July Issue 2IJHMR, Volume
Table 1. The demographic data of the studies included in this meta-analysis showing the prevalence of dysphagia in COVID-19
patients at admission (day 0)
Study
Country
year
Sample
Size
Sex
(male)
Method
Dysphag
ic (Total)
Redd et al.
[21]
United States
2020
318
1
Martin-
Martinez et
al. [22]
Spain
2021
205
98
Subj/
EAT-10
106
Cerutia et al.
[23]
Switzerland
2021
31
25
Subj/
GUSS
17
Ceriana et al.
[24]
Italy
2021
89
63
25
Total
643
186
149
Abbreviations: SD: Standard Deviation; Subj: Subjective; EAT-10: Eating Assessment Tool-10; GUSS: Gugging Swallowing
Screen
Statistical analysis
The meta-analysis was performed to estimate the pooled prevalence of dysphagia in COVID-19 patients. The effect sizes were
expressed as prevalence and also frequency at 95% confidence interval. Random effects were used for statistical analysis.
Table 2. The demographic data of the studies included in this meta-analysis showing the prevalence of dysphagia in COVID-19
patients at discharge
Study
Countr
y
year
Sample
Size
Mean±
SD
age (y)
Sex
(male)
Metho
d
Dyspha
gic
(Total)
Archer et al.
[13]
United Kingdom
2021
99
56.8(16.7)
Subj/
FOIS
29
Ceruti et al.
[16]
Switzerland
2021
31
61 (12)
25
Subj/
GUSS
7
Lima et al. [5]
Brazil
2021
101
53.4(15.9)
66
Subj/
ASHA NOMS
30
Mallart et al.
[25]
France
2022
43
62.9(10.9)
30
10
Martin-
Martinez et al.
[22]
Spain
2021
183
Subj/
EAT-10
82
Ramos et al.
[26]
Spain
2021
936
63.7 ± 15.3
558
Subj/
EAT-10
242
Regan et al.
[27]
Ireland
2021
95
62
69
Subj/
FOIS
26
The Prevalence of Dysphagia in Patients with Covid-19: A Systematic Review and Meta-Analysis
175Page com.ijhmrwww. 3 220 7 July Issue 2IJHMR, Volume
Regan et al.
[28]
Ireland
2021
315
76
194
Subj/
FOIS
142
ReyesTorres
et al. [29]
Mexico
2021
112
54 (12)
92
Subj/
V-VST
46
Gonzalez
Lindh et al.
[30]
Sweden
2021
28
61 (11.9)
22
Subj/
FOIS
10
Hoyois et al.
[31]
Belgium
2021
15
60
10
9
Daunter et al.
[32]
United States
2021
239
66.80 (15.31)
166
29
Ceriana et al.
[24]
Italy
2021
89
61.9 ±11.3
63
6
Total
2286
1295
668
Abbreviations: SD: Standard Deviation; Subj: Subjective; FOIS: Functional Oral Intake Status; GUSS: Gugging Swallowing
Screen; ASHA NOMS: American Speech-Language-Hearing Association National Outcome Measurement System; EAT-10: Eating
Assessment Tool-10; V-VST: Volume-Viscosity Swallow Test
Table 3. The demographic data of the studies included in this meta-analysis showing the prevalence of dysphagia in COVID-19
patients at 3-6 months post-discharge / positive SARS-CoV-2 test
Study
Coun
try
year
Samp
le Size
Mean
±SD
age
(y)
Sex
(male
)
Meth
od
Dysp
ha
gic
(Total
)
Ramos et al. [26]
Spain
2021
62
Subj/
EAT-10
3
Martin-Martinez et
al. [22]
Spain
2021
175
Subj/
EAT-10
42
Martin-Martinez et
al. [22]
Spain
2021
171
Subj/
EAT-10
40
Neevel et al. [33]
United States
2021
24
50
12
6
Allisan-Arrighi et
al. [34]
United States
2022
81
54.23(17.36)
49
16
Wahlgren et al. [35]
Sweden
2021
158
57.4(13.8)
97
13
Huang et al. [36]
China
2021
1655
57
897
69
Leis-Cofiño
et al. [37]
Spain
2021
79
64
48
Subj/
EAT-10
7
Total
2405
1103
196
Abbreviations: SD: Standard Deviation; Subj: Subjective; EAT-10: Eating Assessment Tool-10
Results
The Prevalence of Dysphagia in Patients with Covid-19: A Systematic Review and Meta-Analysis
176Page com.ijhmrwww. 3 220 7 July Issue 2IJHMR, Volume
RESEARCH SELECTION
The present search found 2736 records, of which 2132 were duplicates. The authors reviewed the abstract of 604 articles. Out of
which, 42 studies met the inclusion conditions for full-text review. Finally, 19 articles entered the meta-analysis stage (Fig. 1). In
detail, four studies investigated the prevalence of dysphagia at admission [6, 16, 21, 24], 13 studies focused on the prevalence of
dysphagia at discharge [4-6, 8, 13, 14, 16, 24, 31, 32, 38-40], and the prevalence of dysphagia in the long-term was investigated in
eight studies [6, 33-37, 39]. In the studies that introduced dysphagia assessment tools, all studies used subjective tools to screen for
swallowing disorders (Tables 1 & 2 & 3).
Fig. 1 The PRISMA flowchart (2020) for the selection of the eligible studies for meta-analysis
Meta-analysis results
The study of the clinical data included 19 studies with a total of 643 COVID-19 patients at admission, 2286 COVID-19 patients at
discharge, 2405 COVID-19 patients at 3-6 months post-discharge or after their positive SARS-CoV-2 test result, and 5334 COVID-
19 patients in total. The demographic information of the studies included in this meta-analysis is shown in Tables 1 & 2 & 3. Forest
plot of the prevalence of dysphagia in COVID-19 patients at admission, discharge, and long-term is shown in Fig. 2 . As the results
of the meta-analysis show, the highest prevalence of dysphagia in COVID-19 patients was related to admission with 32%, and the
lowest prevalence of dysphagia in COVID-19 patients was related to 3-6 months later with 14% prevalence. Based on the meta-
analysis results, in total, the average age of these patients was 61.2 years. The average age of patients was different at the time
points. In detail, the mean age of patients at the time of admission, discharge, and 3-6 months post-discharge was 66.5 years, 64.28
years, and 57.11 years, respectively.
The Prevalence of Dysphagia in Patients with Covid-19: A Systematic Review and Meta-Analysis
177Page com.ijhmrwww. 3 220 7 July Issue 2IJHMR, Volume
Fig. 2 Prevalence of dysphagia in COVID-19 patients at admission (day 0), discharge, and long-term
Publication bias detection
The funnel plot based on the total studies is given in Fig. 3. The results show that the studies are asymmetric.
The Prevalence of Dysphagia in Patients with Covid-19: A Systematic Review and Meta-Analysis
178Page com.ijhmrwww. 3 220 7 July Issue 2IJHMR, Volume
Fig. 3 Funnel plot of all studies
DISCUSSION
Based on the results of the present meta-analysis, the prevalence of dysphagia in COVID-19 patients at admission to the hospital is
32%. So, about one-third of COVID-19 patients may experience dysphagia as the only symptom. Ceriana et al. also reported a
similar rate (28%) [24]. Although, a considerable rate of dysphagia has been noted in two recent European studies, with Martinez
et al. reporting 51.7% of COVID-19 patients admitted to the ward and Cerutia et al. reporting 54.8% in COVID-19 patients admitted
to the ICU [6, 16]. According to the results of the present study, dysphagia prevalence in patients diagnosed with COVID-19 at the
time of discharge is very similar to the time of admission and equal to 29%. Similar studies by Archer et al. and Lima et al. reported
similar percentages, 29.2%, and 29.7%, respectively [5, 13]. Although a higher dysphagia rate at these patients’ time of discharge
has also been reported: 45% by Regan et al. and 50% by ReyesTorres et al. [4, 40]. Since the rate of dysphagia is almost the same
at the time of admission and discharge, it can be argued that swallowing therapy for these patients during their hospitalization has
not been attended to as much as necessary. Because Regan et al. showed that if these patients undergo swallowing therapy, the
results will be notable; They reported after treatment implementation in hospitalized patients the prevalence of dysphagia decreased
from 86% to 27% at the time of discharge [8]. However, In a study conducted by Cerutia et al. comparing the prevalence of dysphagia
between COVID-19 patients and Non-COVID-19 patients, a higher rate of dysphagia was observed in COVID-19 patients with
faster recovery [16]. Concerns regarding the transmission of the virus via aerosol-generating procedures in addition to the lack of
instrumental assessments might have resulted in the altered amount and varied forms of management provided during pandemic
waves. Other influencing issues may include SLP services in ICU settings, dysphagia training, and access to personal protective
equipment [8].
Many organs in the body in addition to the lungs can be impacted by COVID-19 and this damage increases the danger of long-term
health complications [7]. In the present study, the authors illustrated the prevalence of dysphagia in patients diagnosed with COVID-
19 in the long term. However, the prevalence (14%) in the analysis was small, it was not negligible and it required therapeutic
intervention; Because a study conducted by Martin-Martinez et al. demonstrated that dysphagia is relevant to increased 6-month
mortality [6]. According to Neevel et al.'s study, this prevalence goes up to 25% [33]. The form of pneumonia caused by COVID-
19 can result in long-term injury to the lungs’ air sacs. And the long-term breathing difficulties caused by the scar tissue can lead to
weak coordination of swallowing and breathing predisposing [7]. Furthermore, risks for developing swallowing impairments can
also occur due to other injuries caused by COVID-19. As Aoyagi et al. described the COVID-19 infection may cause damage to the
X and IX cranial nerves [41]. Post-acute COVID-19 Swallowing disorder is probably caused by a multiplicity of reasons [7].
However, this rate of dysphagia has been halved since hospital discharge. As found in studies, the prevalence of dysphagia is directly
related to the severity of the disease [38] and intubation [4]. Therefore, after the discharge and recovery from COVID-19 and
reducing the burden of the disease, the rate of dysphagia decreased. Also, by reducing the injuries caused by intubation, the rate of
dysphagia is expected to decline. Another potential reason for this reduction is post-discharge rehabilitation service delivery in the
community [35].
The Prevalence of Dysphagia in Patients with Covid-19: A Systematic Review and Meta-Analysis
179Page com.ijhmrwww. 3 220 7 July Issue 2IJHMR, Volume
As we have shown, the average age is the highest at the time of admission and decreases at the time of discharge and follow-up.
The decrease in the average age after discharge may be due to the death of very old patients after discharge from the hospital [6].
Perhaps older patients did not cooperate for re-testing of dysphagia after discharge and did not return for re-evaluation (due to old
age, comorbidities, or long-term complications of COVID-19) [6] and most of the younger patients have cooperated and returned
for re-examination. Another reason for this could be the small and limited number of studies that have included the average age for
day 0 [6, 16, 21].
In total, 24% of patients affected with COVID-19 suffer from dysphagia, which is a significant frequency. Data on swallowing
difficulties in these patients would inform inpatient and outpatient service delivery [4, 8]. The present data indicate that SLPs should
be included both in hospitals and outpatient multidisciplinary COVID-19 clinics in society [8]. Early evaluation of suspected
subjects is required for timely intervention to avoid further consequences [4].
CONCLUSION
About a quarter of patients with COVID-19 may have dysphagia (swallowing difficulties) during the acute phase and/or also in the
post-acute phase of the disease. Therefore, one should be aware of the symptoms of dysphagia and treat it in time. Hospitals,
multidisciplinary clinics, and SLPs will always play a vital role in evaluating, diagnosing, and treating people with COVID-19related
swallowing disorders.
Compliance with Ethical Standards
Conflict of interest
The authors declared no conflict of interest.
REFERENCES
1. Sharma, P., et al., Prevalence of oral manifestations in COVID19: A systematic review. Reviews in medical virology,
2022: p. e2345. https://doi.org/10.1002/rmv.2345
2. Hesni, E., et al., Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in
Kermanshah Province, Iran: a retrospective one-year cohort study. BMC infectious diseases, 2022. 22(1): p. 1-12.
https://doi.org/10.1186/s12879-022-07312-7
3. Aghaz, A., et al., Prevalence of Dysphonia in Patients with COVID-19: A Systematic Review and Meta-Analysis. Modern
Rehabilitation, 2022. 16(2). https://doi.org/10.18502/jmr.v16i2.9299
4. Regan, J., et al., Dysphagia, Dysphonia, and Dysarthria Outcomes Among Adults Hospitalized With COVID19 Across
Ireland. The Laryngoscope, 2022. 132(6): p. 1251-1259 https://doi.org/10.1002/lary.29900
5. Lima, M.S.d., et al., Preliminary results of a clinical study to evaluate the performance and safety of swallowing in critical
patients with COVID-19. Clinics, 2020. 75. DOI: 10.6061/clinics/2020/e2021
6. MartinMartinez, A., et al., COVID-19 is associated with oropharyngeal dysphagia and malnutrition in hospitalized
patients during the spring 2020 wave of the pandemic. Clinical Nutrition, 2022. 41(12): p. 2996-3006.
https://doi.org/10.1016/j.clnu.2021.06.010
7. Marchese, M.R., et al., Oropharyngeal dysphagia after hospitalization for COVID-19 disease: our screening results.
Dysphagia, 2022. 37(2): p. 447-453. https://doi.org/10.1007/s00455-021-10325-0
8. Regan, J., et al., Postextubation dysphagia and dysphonia amongst adults with COVID19 in the Republic of Ireland: A
prospective multisite observational cohort study. Clinical Otolaryngology, 2021. 46(6): p. 1290-1299.
https://doi.org/10.1111/coa.13832
9. Mallart, R., et al., Prevalence and evaluation of oropharyngeal dysphagia in SARS-CoV2 infection in intensive care unit.
The Journal of Laryngology and Otology, 2022: p. 1-14. DOI: 10.1017/s0022215121004710
10. Lechien, J.R., et al., Features of mild-to-moderate COVID-19 patients with dysphonia. Journal of Voice, 2020.
https://doi.org/10.1016/j.jvoice.2020.05.012
11. Mohan, R. and B. Mohapatra, Shedding light on dysphagia associated with COVID-19: the what and why. OTO open,
2020. 4(2): p. 2473974X20934770. DOI: 10.1177/2473974X20934770
12. Eyigör, S. and E. Umay, Dysphagia management during COVID-19 pandemic: A review of the literature and international
guidelines. Turkish Journal of Physical Medicine and Rehabilitation, 2021. 67(3): p. 267. doi: 10.5606/tftrd.2021.8427
13. Archer, S.K., C.M. Iezzi, and L. Gilpin, Swallowing and voice outcomes in patients hospitalized with COVID-19: an
observational cohort study. Archives of Physical Medicine and Rehabilitation, 2021. 102(6): p. 1084-1090.
https://doi.org/10.1016/j.apmr.2021.01.063
14. Lindh, M.G., et al., Swallowing function in COVID-19 patients after invasive mechanical ventilation. Archives of
Rehabilitation Research and Clinical Translation, 2022. 4(1): p. 100177. https://doi.org/10.1016/j.arrct.2021.100177
The Prevalence of Dysphagia in Patients with Covid-19: A Systematic Review and Meta-Analysis
180Page com.ijhmrwww. 3 220 7 July Issue 2IJHMR, Volume
15. MartinMartinez, A., et al., COVID-19 is associated with oropharyngeal dysphagia and malnutrition in hospitalized
patients during the spring 2020 wave of the pandemic. Clinical Nutrition, 2021. https://doi.org/10.1016/j.clnu.2021.06.010
16. Ceruti, S., et al., Dysphagic disorder in a cohort of COVID-19 patients: Evaluation and evolution. Annals of Medicine and
Surgery, 2021. 69: p. 102837. https://doi.org/10.1016/j.amsu.2021.102837
17. Wu, Z. and J.M. McGoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19)
outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. jama,
2020. 323(13): p. 1239-1242. doi:10.1001/jama.2020.2648
18. Sadeghi, Z., et al., Depression, anxiety, and stress relative to swallowing impairment in persons with multiple sclerosis.
Dysphagia, 2021. 36(5): p. 902-909. https://doi.org/10.1007/s00455-020-10207-x
19. Page, M.J., et al., The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Systematic reviews,
2021. 10(1): p. 1-11. https://doi.org/10.1016/j.ijsu.2021.105906
20. Margulis, A.V., et al., Quality assessment of observational studies in a drug-safety systematic review, comparison of two
tools: the NewcastleOttawa scale and the RTI item bank. Clinical epidemiology, 2014. 6: p. 359.
21. Redd, W.D., et al., Prevalence and characteristics of gastrointestinal symptoms in patients with severe acute respiratory
syndrome coronavirus 2 infection in the United States: a multicenter cohort study. Gastroenterology, 2020. 159(2): p. 765-
767. e2. https://doi.org/10.1053/j.gastro.2020.04.045
22. Martin-Martinez, A., et al., COVID-19 is associated with oropharyngeal dysphagia and malnutrition in hospitalized patients
during the spring 2020 wave of the pandemic. Clinical Nutrition, 2021. https://doi.org/10.1016/j.clnu.2021.06.010
23. Glotta, A., et al., Dysphagic disorder in a cohort of COVID-19 patients: evaluation and evolution. medRxiv, 2021.
https://doi.org/10.1101/2021.06.20.21258947
24. Ceriana, P., et al., Usefulness of step down units to manage survivors of critical Covid-19 patients. European Journal of
Internal Medicine, 2021. 88: p. 126-128. https://doi.org/10.1016/j.ejim.2021.03.002
25. Mallart, R., et al., Prevalence and evaluation of oropharyngeal dysphagia in SARS-CoV2 infection in intensive care unit.
The Journal of Laryngology & Otology, 2022: p. 1-14. DOI: 10.1017/s0022215121004710
26. Ramos, A., et al., Impact of COVID-19 on nutritional status during the first wave of the pandemic. Clinical Nutrition, 2021.
https://doi.org/10.1016/j.clnu.2021.05.001
27. Regan, J., et al., Post-Extubation Dysphagia and Dysphonia amongst Adults with COVID-19 in the Republic of Ireland: a
Prospective Multi-Site Observational Cohort Study. Authorea Preprints, 2021. https://doi.org/10.1111/coa.13832
28. Regan, J., et al., Dysphagia, Dysphonia, and Dysarthria Outcomes Among Adults Hospitalized With COVID19 Across
Ireland. The Laryngoscope, 2021. https://doi.org/10.1002/lary.29900
29. ReyesTorres, C.A., et al., Phase angle and overhydration are associated with postextubating dysphagia in patients with
COVID19 discharged from the ICU. Nutrition in Clinical Practice, 2021. https://doi.org/10.1002/ncp.10781
30. Lindh, M.G., et al., Swallowing function in COVID-19 patients after invasive mechanical ventilation. Archives of
Rehabilitation Research and Clinical Translation, 2022: p. 100177. https://doi.org/10.1016/j.arrct.2021.100177
31. Hoyois, A., et al., Nutrition evaluation and management of critically ill patients with COVID19 during postintensive care
rehabilitation. Journal of Parenteral and Enteral Nutrition, 2021. 45(6): p. 1153-1163. https://doi.org/10.1002/jpen.2101
32. Daunter, A.K., et al., Functional decline in hospitalized patients with COVID19 in the early months of the pandemic.
PM&R, 2022. 14(2): p. 198-201. https://doi.org/10.1002/pmrj.12624
33. Neevel, A.J., et al., Postacute COVID-19 Laryngeal injury and dysfunction. OTO open, 2021. 5(3): p.
2473974X211041040. DOI: 10.1177/2473974X211041040
34. AllisanArrighi, A.E., et al., Longterm upper aerodigestive sequelae as a result of infection with COVID19. Laryngoscope
Investigative Otolaryngology, 2022. 7(2): p. 476-485. https://doi.org/10.1002/lio2.763
35. Wahlgren, C., et al., Rehabilitation needs following COVID-19: Five-month post-discharge clinical follow-up of
individuals with concerning self-reported symptoms. EClinicalMedicine, 2022. 43: p. 101219.
https://doi.org/10.1016/j.eclinm.2021.101219
36. Huang, C., et al., 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet,
2021. 397(10270): p. 220-232. https://doi.org/10.1016/S0140-6736(20)32656-8
37. Leis-Cofiño, C., et al., Persistent dysphonia in hospitalized COVID-19 patients. Journal of Voice, 2021.
https://doi.org/10.1016/j.jvoice.2021.07.001
38. Mallart, R., et al., Prevalence and evaluation of oropharyngeal dysphagia in SARS-CoV2 infection in intensive care unit.
The Journal of Laryngology and Otology, 2022: p. 1-14. DOI: 10.1017/s0022215121004710
39. Ramos, A., et al., Impact of COVID-19 on nutritional status during the first wave of the pandemic. Clinical nutrition, 2022.
41(12): p. 3032-3037. https://doi.org/10.1016/j.clnu.2021.05.001
The Prevalence of Dysphagia in Patients with Covid-19: A Systematic Review and Meta-Analysis
181Page com.ijhmrwww. 3 220 7 July Issue 2IJHMR, Volume
40. ReyesTorres, C.A., et al., Phase angle and overhydration are associated with postextubating dysphagia in patients with
COVID19 discharged from the ICU. Nutrition in Clinical Practice, 2022. 37(1): p. 110-116.
https://doi.org/10.1002/ncp.10781
41. Aoyagi, Y., et al., Oropharyngeal dysphagia and aspiration pneumonia following coronavirus disease 2019: a case report.
Dysphagia, 2020. 35(4): p. 545-548. https://doi.org/10.1007/s00455-020-10140-z
... Accordingly, the data reported in different countries are contradictory depending on the methodology [41]. On the other hand, these contradictions can be attributed to racial differences in the CO-VID-19 demonstrations [19,42]. ...
Article
Full-text available
Introduction: The world has been suffering from COVID-19 since 2020 and the disease continues today. This is thought that COVID-19 patients are at high risk for dysphagia and dysphonia. We aimed to determine the prevalence of dysphonia and dysphagia and identify correlated factors to develop dysphagia and dysphonia in COVID-19 patients admitted to the intensive care units (ICU). Materials and Methods: 70 patients with COVID-19 (M age=63.1 years, SD=18.6; males=39) hospitalized in the ICU were evaluated by an expert Speech and Language Pathologist (SLP). Patients were evaluated for swallowing disorder by means of the Mann Assessment of Swallowing Ability and the Persian version of the Functional Oral Intake Scale. Consensus Auditory-Perceptual Evaluation of Voice also was used to evaluate voice disorders. Results: Overall, 58.6% of patients presented dysphagia, and 74.3% of patients had dysphonia. 34.3% of the patients were on mechanical ventilation (MV). A correlation was seen among dysphagia severity and the number of MV days, the length of stay (LOS), and age (P<0.05). Dyspnea is effective on the prevalence of dysphonia and dysphagia in COVID-19 patients (P<0.05). Vomiting has been effective on only the prevalence of dysphagia (P<0.05). Furthermore, a significant correlation was found between dysphagia and dysphonia (P<0.01). Conclusion: It was found that there is a high prevalence rate of dysphagia and dysphonia in patients with COVID-19 admitted to the ICUs. Early evaluation by SLP is essential to identify the suspected patients and early intervention to prevent further complications and improve their quality of life.
Article
Full-text available
Abstract Background Since the first official report of SARS-CoV-2 infection in Iran on 19 February 2020, our country has been one of the worst affected countries by the COVID-19 epidemic in the Middle East. In addition to demographic and clinical characteristics, the number of hospitalized cases and deaths is an important factor for evidence-based decision-making and disease control and preparing the healthcare system to face the future challenges of COVID-19. Therefore, this cohort study was conducted to determine the demographics, clinical characteristics, and outcomes of hospitalized COVID-19 patients in Kermanshah Province, west of Iran. Methods This multicenter retrospective cohort study included all suspected, probable, and confirmed cases of COVID-19 hospitalized in Kermanshah Province, Iran during the first year of the COVID-19 pandemic. Demographics, clinical characteristics, outcomes and other additional information of hospitalized patients were collected from the COVID-19 database of the Medical Care Monitoring Center (MCMC) of Kermanshah Province. Results Kermanshah Province experienced three waves of COVID-19 infection considering the hospitalization and mortality rates between February 20, 2020 and February 19, 2021. A total of 27,256 patients were included in the study: 5203 (19.09%) subjects were suspected, 9136(33.52%) were probable, and 12,917 (47.39%) were confirmed COVID-19 cases. The mean age of the patients was 53.34 ± 22.74 years and 14,648 (53.74%) were male. The median length of hospital stay among COVID-19 survivors and non-survivors patients were 4 (interquartile range [IQR] 1–6) and 4 (IQR 1–8) days, respectively. Among patients with COVID-19, 2646 (9.71%) died during hospitalization. A multivariable logistic regression revealed that odds of death among patients ≥ 85 years was significantly greater than among patients
Article
Full-text available
Objectives Respiratory, voice, and swallowing difficulties after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) may result secondary to upper airway disease from prolonged intubation or mechanisms related to the virus itself. We examined a cohort who presented with new laryngeal complaints following documented SARS‐CoV‐2 infection. We characterized their voice, airway, and/or swallowing symptoms and reviewed the clinical course of their complaints to understand how the natural history of these symptoms relates to COVID‐19 infections. Methods Retrospective review of patients who presented to our department with upper aerodigestive complaints as sequelae of prior infection with, and management of, SARS‐CoV‐2. Results Eighty‐one patients met the inclusion criteria. Median age was 54.23 years (±17.36). Most common presenting symptoms were dysphonia (n = 58, 71.6%), dysphagia/odynophagia (n = 16, 19.75%), and sore throat (n = 9, 11.11%). Thirty‐one patients (38.27%) presented after intubation. Mean length of intubation was 16.85 days (range 1–35). Eighteen patients underwent tracheostomy and were decannulated after an average of 70.69 days (range 23–160). Patients with history of intubation were significantly more likely than nonintubated patients to be diagnosed with a granuloma (8 vs. 0, respectively, p < .01). Fifty patients (61.73%) were treated for SARS‐CoV‐2 without requiring intubation and were significantly more likely to be diagnosed with muscle tension dysphonia (19 vs. 1, p < .01) and laryngopharyngeal reflux (18 vs. 1, p < .01). Conclusion In patients with persistent dyspnea, dysphonia, or dysphagia after recovering from SARS‐CoV‐2, early otolaryngology consultation should be considered. Accurate diagnosis and prompt management of these common underlying etiologies may improve long‐term patient outcomes. Level of evidence 4
Article
Full-text available
Background: The aim of this study was to estimate the prevalence of dysphonia in patients with COVID-19. Methods: English and Persian studies that reported dysphonia in patients with COVID-19were included. Review and case report studies were excluded. We searched Web of Science, PubMed, Google Scholar, and Scopus from 1 January 2020 until 15 July 2021. The prevalence of dysphonia was obtained by combining the results and weighting the sample size in the corresponding study. Heterogeneity was evaluated using the Cochran Chi-square test and I2. Results: Of the 1830 articles identified, 7 studies finally (n= 1410 patients) were included in the meta-analysis. Pooled prevalence of the dysphonia was 31% (95%CI:13-.48). The prevalence of dysphonia in men and women with COVID-19 was 28.2% (95%CI:14-.46) and 32.8 (95%CI:.22-.45), respectively. Conclusion: About one-third of patients with COVID-19 may have dysphonia as the only symptom. Therefore, one should even be careful in approaching those who have only dysphonia.
Article
Full-text available
Objective To explore swallowing function and risk factors associated with delayed recovery of swallowing in COVID-19 patients post invasive mechanical ventilation using the Functional Oral Intake Scale (FOIS). Design Longitudinal cohort study. Setting 3 secondary-level hospitals. Participants Invasively ventilated patients (n=28), hospitalized with severe COVID-19 who were referred to the Speech and Language Pathology (SLP) departments post mechanical ventilation between March 5 and July 5 2020 for an evaluation of swallowing function before commencing oral diet. Interventions SLP assessment, advice and therapy for dysphagia. Main outcome measures Oral intake levels at baseline and hospital discharge according to the Functional Oral Intake Scale (FOIS). Patients were stratified according to FOIS (1-5=dysphagia, 6-7= functional oral intake). Data regarding comorbidities, frailty, intubation and tracheostomy, proning and SLP evaluation were collected. Results Dysphagia was found in 71% of the patients at baseline (in total 79% male, age 61 ±12 years, BMI 30 ±8 kg/m²). Median FOIS score at baseline was 2 (IQR 1) vs 5 (IQR 2.5) at hospital discharge. Patients with dysphagia were older (64 ±8.5 vs 53 ±16 years; p= 0.019), had a higher incidence of hypertension (70% vs 12%; p=0.006) were ventilated invasively longer (16 ±7 vs 10 ±2 days; p=0.017) or with tracheostomy (9 ±9 vs 1 ±2 days; p=0.03) longer. A negative association was found between swallowing dysfunction at bedside and days hospitalized (r=-0.471, p=0.01), and number of days at the Intensive Care Unit (ICU) (r=-0.48, p=0.01). Conclusion Dysphagia is prevalent in COVID-19 patients post invasive mechanical ventilation and is associated with number of days in hospital and number of days in the ICU. Swallowing function and tolerance of oral diet improved at discharge (p<0.001).
Article
Full-text available
Background This report describes and objectivizes reported problems among a cohort of previously hospitalized COVID-19 patients by clinical examination and determination of the required level of rehabilitation sevices. Methods This report forms part of the Linköping COVID-19 Study (LinCoS) that included 745 individuals from one of 21 Swedish healthcare regions, Region Östergötland (RÖ), admitted to hospital for COVID-19 during March 1st–May 31st, 2020. In this descriptive ambidirectional cohort study, all 185 individuals who had reported concerning persisting symptoms were invited to a multi-professional clinical assessment of somatic, functional, affective, neuropsychological status and rehabilitation needs. Rehabilitation needs were assessed using three sub-scales of the Rehabilitation Complexity Scale-Extended. Findings Among the 158 (85·4%) cases consenting and included in the analysis, we found a broad array of symptoms and signs attributable to COVID-19 involving respiratory, visual, auditory, motor, sensory and cognitive functions that could be confirmed clinically at five months post-discharge. This translated into 16% [95% CI 13–20] of survivors (70/433) of the total regional cohort of hospitalised patients requiring further rehabilitative interventions at follow-up. Weakness in extremities was reported in 28·5% [21·6, 36·2] (45/158). On examination, clinically overt muscle weakness could be corroborated in 15 individuals (10·5%) [6·1, 16·4]. 48% [40, 56] (76/158) reported cognitive symptoms, while the physician noted overt cognitive impairments in only 3% [1·1, 7·5]. In neuropsychological testing, 37% [28–46] (45/122) performed 1.5 SD below the norm, indicating neurocognitive deficits. Fifty-five individuals (34·8%) [27·4, 42·8] reported new or aggravated pain. In three fourths of them, it exerted a ‘moderate’ or worse detrimental effect on their ability to work. Interpretation Our study underscores the importance of providing extensive examination of cases with persisting problems after COVID-19, especially since symptoms such as fatigue and breathlessness are highly nonspecific, but may represent significant underlying functional impairments. Robust neurocognitive testing should be performed, as cognitive problems may easily be overlooked during routine medical consultation. In the Swedish context, most rehabilitative interventions could be provided in a primary care setting. A substantial minority of patients should be triaged to specialized rehabilitation services.
Article
Full-text available
In this review, we present the safest and most effective diagnosis and treatment approaches to dysphagia during the novel coronavirus-2019 (COVID-19) pandemic in the light of available data, relevant literature, and personal experiences. Evaluations for dysphagia patients should be based on clinical assessment during the COVID-19 pandemic and instrumental assessment should be planned for very few number of patients. The main approach to rehabilitation must depend on compensatory methods, texture-modified foods, and postural strategies. Direct treatment methods should be avoided and home-based exercise programs should be encouraged. It is also obvious that there is a need for the development of new strategies for telemedicine/telerehabilitation practices in the new world order. © 2021 Turkish Society of Physical Medicine and Rehabilitation. All rights reserved.
Article
Full-text available
Objective: To investigate the presence, degree, predictors, and trajectory of dysphagia, dysphonia, and dysarthria among adults hospitalized with COVID-19 across the Republic of Ireland (ROI) during the first wave of the pandemic. Study design: Prospective observational cohort study. Methods: Adults with confirmed COVID-19 who were admitted into 14 participating acute hospitals across ROI and referred to speech and language therapy between March 1st and June 30th, 2020 were recruited. Outcomes obtained at initial SLT evaluation and at discharge were oral intake status (Functional Oral Intake Scale), perceptual voice quality (GRBAS), and global dysarthria rating (Dysarthria Severity Scale). Results: Data from 315 adults were analyzed. At initial SLT assessment, 84% required modified oral diets, and 31% required tube feeding. There were high rates of dysphonia (42%) and dysarthria (23%). History of intubation (OR 19.959, 95% CI 6.272, 63.513; P = .000), COVID-19 neurological manifestations (OR 3.592, 95% CI 1.733, 7.445; P = .001), and age (OR 1.034; 95% CI 1.002, 1.066; P = .036) were predictive of oral intake status. History of intubation was predictive of voice quality (OR 4.250, 95% CI 1.838, 9.827; P = .001) and COVID-19 neurological manifestations were predictive of dysarthria (OR 2.275; 95% CI 1.162, 4.456; P = .017). At discharge, there were significant improvements in oral intake (Z = -7.971; P = .000), voice quality (Z = -5.971; P = .000), and dysarthria severity (Z = -2.619; P = .009), although need for modified oral intake (59%), dysphonia (23%), and dysarthria (14%) persisted. Conclusion: Dysphagia, dysphonia, and dysarthria were widespread among adults hospitalized with COVID-19 and they persisted for many at discharge. Prompt SLT evaluation is required to minimize complications. Level of evidence: 3 Laryngoscope, 2021.
Article
Full-text available
Background: Few studies have evaluated the prevalence of post-extubation dysphagia and associated factors in patients with coronavirus disease 2019 (COVID-19) . Our study assessed the prevalence of post-extubation dysphagia and body composition in patients with COVID-19 discharged from an intensive care unit (ICU). Methods: A prospective cohort study was performed in post-ICU extubated patients with acute respiratory distress syndrome related to COVID-19 in two referral hospitals. A total of 112 patients were evaluated and included; swallowing assessment and bioelectrical impedance analysis (BIA) were performed after extubation and discharge from the ICU. To identify associations between dysphagia, lower phase angle (PhA) (<4.8°) and hydration (extracellular water/total body water < 0.390) logistic and linear regression analyses were conducted. Results: The incidence of post-extubation dysphagia was 41% (n = 46). From these, 65% (n = 30) had severe swallowing impairment. Overhydration and PhA were significantly different in patients with dysphagia, and segmental hydration in the trunk and legs was higher than in arms. PhA <4.8° (odds ratio [OR], 12.2; 95% CI, 4.3-34.1; P < .05) and overhydration measured by BIA (OR, 9.1; 95% CI, 3.4-24.5; P < .05) were associated with post-extubation dysphagia in multivariate analysis. PhA (<4.8°) was associated with a lower rate of swallowing recovery at hospital discharge (log-rank test = 0.007). Conclusions: A high incidence of post-extubation dysphagia was found in patients with COVID-19. Low PhA and overhydration were associated with the presence of dysphagia. Lower PhA was an independent factor for swallowing recovery at discharge.
Article
Coronavirus disease 2019 (COVID‐19) is a novel disease caused by a newly identified virus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) causing diverse systemic manifestations. The oral cavity too is not spared and the symptoms appear either independently, concurrently, or sequentially. In view of the rising documented cases of oral lesions of COVID‐19, this systematic review aims to assess the prevalence of oral manifestations in COVID‐19 confirmed individuals. An extensive literature search was conducted in databases like Scopus, Pubmed/Medline, Livivo, Lilacs and Google Scholar and varied oral signs and symptoms were reported as per the PRISMA guidelines. Studies published in English language literature only were included and were subjected to the risk of bias using the Joana Briggs Institute Appraisal tools for prevalence studies, case series and case reports. In a two‐phase selection, 34 studies were included: 21 observational, 3 case‐series and 10 case reports. These observational studies included approximately 14,003 patients from 10 countries. In this review, we explored the most commonly encountered oral and dental manifestations in COVID‐19 and identified that loss of taste acuity, xerostomia and anosmia were frequently reported. Elevated incidence of opportunistic infections like mucormycosis and aspergillosis were reported during the treatment due to prolonged intake of steroids. Immunosuppression and poor oral hygiene led to secondary manifestations like enanthematous lesions. However, it is not clear that oral signs and symptoms are due to COVID‐19 infection itself or are the result of extensive treatment regimen followed [PROSPERO CRD42021258264].
Article
Objective: The main objective was to assess the prevalence of dysphagia in the intensive care unit in patients with coronavirus disease 2019.Methods. A cohort, observational, retrospective study was conducted of patients admitted to the intensive care unit for severe acute respiratory syndrome coronavirus 2 pneumonia at the University Hospital of Rouen in France. Results: Over 4 months, 58 patients were intubated and ventilated, 43 of whom were evaluated. Screening revealed post-extubation dysphagia in 62.7 per cent of patients. In univariate analysis, a significant association was found between the presence of dysphagia and: the severity of the initial pathology, the duration of intubation, the duration of curare use, the degree of muscle weakness and the severity indicated on the initial scan. At the end of intensive care unit treatment, 22 per cent of the dysphagic patients had a normal diet, 56 per cent had an adapted diet and 22 per cent still received exclusive tube feeding. Conclusion: Post-extubation dysphagia is frequent and needs to be investigated.